TNBC OncoSec Medical Tavo
OncoSec starts Phase II trial of Tavo and Keytruda for TNBC
OncoSec Medical has started the Phase II KEYNOTE-890 clinical trial of Tavo for the treatment of late-stage triple negative breast…
OncoSec Medical has started the Phase II KEYNOTE-890 clinical trial of Tavo for the treatment of late-stage triple negative breast…